CRISPR (CRSP) Long-Term Debt to Capital Ratio
CRISPR Therapeutics AG (CRSP) is implementing ethical governance standards in gene therapy, minimizing the environmental impact of its corporate operations. Meanwhile, the ecological focus remains secondary, limited to energy efficiency and bio-waste disposal. This price chart demonstrates the metric at 0.46. Business prospects rely on the market launch of Casgevy and advancements in developing modified CAR-T cells to combat cancer.
Comprehensive metric breakdowns and analytics for CRISPR Therapeutics AG (CRSP)
- current price and projected stock value:
- market capitalization details:
- issuer book value statistics:
- debt and solvency information:
All Debt to Shareholders' Equity Ratio CRISPR Therapeutics AG|CRSP - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient crisprtx.com|CRSP - Company Debts|Debts to Net Assets CRISPR Therapeutics AG|CRSP - Company Long-Term Debt|Current Liabilities CRISPR Therapeutics|Intermediate Coverage Ratio crisprtx.com
- net income and valuation ratios data:
Comprehensive company analysis:CRISPR Therapeutics AG
CRISPR Therapeutics AG (CRSP) is investing colossal funds into the development of gene therapies while facing uncertainty regarding insurance reimbursements and risks of side effects. This metric measures the share of borrowed funds with a maturity of more than one year within the equity structure, allowing for an assessment of the company's financial stability amid capital-intensive research through the ratio of long-term liabilities to equity.
Analysis of competing companies
Long-Term Debt to Capital Ratio TEM (Tempus)|Long-Term Debt to Equity Qiagen Group (QGEN)|Isis Pharmaceuticals - Long-Term Debt to Capital Ratio|Long-Term Debt to Capital RGEN (Repligen Corporation)|Long-Term Debt to Capital aviditybiosciences.com RNA|GeneDx - Long-Term Debt to Capital|Ultragenyx Pharmaceutical Inc. (RARE) - Long-Term Debt to Equity Ratio|Beam Therapeutics Corp (BEAM) - Long-Term Debt to Equity|Sarepta Corp - Long-Term Debt to Capital Coefficient|TWST (Twist Bioscience) - Long-Term Debt to Capital|10xgenomics.com (TXG) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Intellia Therapeutics, Inc. (NTLA)|Ratio of Long-Term Indebtedness to Capital Stoke Therapeutics Inc|Long-Term Debt to Equity BioLife Corp BLFS|WVE (Wave Pharma) - Long-Term Liabilities to Equity|MAZE - Long-Term Debt to Equity|Long-Term Debt to Capital Coefficient SION (sionnatx.com)|PRME (Prime Medicine) - Long-Term Debt to Equity Ratio|Taysha Gene Therapies Inc - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity Ratio QURE|MGTX (MeiraGTx Corp) - Long-Term Loans to Capital Ratio|Long-Term Debt to Capital RGNX|SLDB (solidbio.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital OCGN (Ocugen)|Pacific Biosciences of California, Inc. (PACB) - Long-Term Liabilities to Capital|BNTC - Long-Term Debt to Equity|Long-Term Debt to Capital Coefficient DSGN (Design Corp)|RCKT: Long-Term Debt to Capital|4dmoleculartherapeutics.com (FDMT) - Long-Term Debt to Capital|Long-Term Debt to Equity Lexeo Therapeutics Inc.|Korro Bio, Inc - Long-Term Liabilities to Equity|Long-Term Debt to Capital EDIT|SLN - Long-Term Liabilities to Capital|ProQR Therapeutics - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Codexis Inc CDXS|SGMO: Long-Term Debt to Equity Ratio|Nautilus Biotechnology - Long-Term Loans to Capital Ratio|MGX: Long-Term Debt to Capital|DTIL - Ratio of Long-Term Indebtedness to Capital|GBIO (Generation Bio Co) - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio boundlessbio.com (BOLD)|Long-Term Debt to Equity Exicure, Inc. (XCUR)|Ratio of Long-Term Indebtedness to Capital imunon.com|Phio Pharmaceuticals Corp. - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient MBIO|TransCode - Long-Term Debt to Capital|BNGO - Long-Term Debt to Capital|APDN: Long-Term Debt to Capital|Long-Term Indebtedness to Equity bluebird bio Inc. BLUE|IPA (ImmunoPrecise Antibodies Ltd) - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio Omega Therapeutics Corp (OMGA)|Long-Term Debt to Equity Singular Genomics Systems (OMIC)|RGLS (regulusrx.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity Syros Pharmaceuticals, Inc. SYRS|Ratio of Long-Term Indebtedness to Capital Telesis Bio Inc. (TBIO)|TCON - Long-Term Debt to Equity|Long-Term Liabilities to Equity UBX